A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic Resistance

Therapeutic resistance remains the most challenging aspect of treating cancer. Raf kinase inhibitory protein (RKIP) emerged as a molecule capable of sensitizing cancerous cells to radio- and chemotherapy. Moreover, this small evolutionary conserved molecule, endows significant resistance to cancer t...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mulla, Fahd, Bitar, Milad S., Feng, Jingwei, Park, Sungdae, Yeung, Kam C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261143/
https://www.ncbi.nlm.nih.gov/pubmed/22279539
http://dx.doi.org/10.1371/journal.pone.0029532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3261143/
https://www.ncbi.nlm.nih.gov/pubmed/22279539
http://dx.doi.org/10.1371/journal.pone.0029532

Ejemplares similares